Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 26806
Evènement :Admet

Dates :Lundi 09 Juillet 2018 - Mardi 10 Juillet 2018

Lieu :Holiday Inn Kensington Forum
97 Cromwell Rd Kensington
SW7 4DN London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

 

Chaired by Eric Bloome, Vice President, Global Pre-Clinical Safety Senior Research Fellow, AbbVie
 
Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times.
The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.
*Source: http://bit.ly/2hMJcgU 
 
Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!
Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro / ex vivo / in vivo / in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.
 
This event is CPD accredited.
 
The ADMET conference will cover new developments in all areas of the ADMET sector, from the evaluation of novel PBPK modelling techniques to the validation of humanised mice models.
 
Join us this year in July to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:
ADME/PK Optimisation for Drug Design and Discovery 
Physiochemical Assessments
Drug Screening Technology 
In Vitro to Human In Vivo Translation 
DMPK, PBPK and PKPD Modelling
Pre-/Clinical Toxicity 
Biopharmaceuticals
Accurate First-in-Human Dose Predictions 
Transporters, Bioavailability, Formulation 
Metabolism Studies
Drug-Drug Interactions
 
URLs:
Website:https://go.evvnt.com/207470-0?pid=4319
Brochure:https://go.evvnt.com/207470-1?pid=4319
Booking:https://go.evvnt.com/207470-2?pid=4319
 
Prices:      
Conference Only: GBP 1499
Distribution of your company's promotional literature to all conference attendees: GBP 999,
Access to the conference documentation on the Document Portal: GBP 499,
The Conference Presentations - paper copy: GBP 499
 
Speakers: Eric Bloome, Pau Aceves, Peter Littlewood, Filipe Lopes, Andreas Reichel, Laurent Salphati,     Timothy Schulz-Utermoehl, Kunal Taskar, Robert Van Waterschoot, Ian Wilson
 
Time: 8:30 am to 4:30 pm

Lieu

Plan et itinéraire
Adresse de la conférence :
Holiday Inn Kensington Forum
97 Cromwell Rd Kensington
SW7 4DN London
Royaume-Uni
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

Admet Pharmacie
admet, absorption, distribution, metabolism, excretion, toxicology, in vivo, in vitro
Professionnels
-- -- --
English

Divers

Pour plus d'informations sur Admet, veuillez contacter SMi Group

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement